BioloBri 🧬👩🏻🔬✨
@biolobri.bsky.social
Reposted by BioloBri 🧬👩🏻🔬✨
Let's iterate, not obliterate.
The US's research infrastructure is a thing of beauty.
Is its continued evolution necessary? Always! That's good policy and good science.
But, our primary focus should be expanding and strengthening the NIH, not stalling it. (4/4) 🧪
The US's research infrastructure is a thing of beauty.
Is its continued evolution necessary? Always! That's good policy and good science.
But, our primary focus should be expanding and strengthening the NIH, not stalling it. (4/4) 🧪
January 23, 2025 at 5:56 PM
Let's iterate, not obliterate.
The US's research infrastructure is a thing of beauty.
Is its continued evolution necessary? Always! That's good policy and good science.
But, our primary focus should be expanding and strengthening the NIH, not stalling it. (4/4) 🧪
The US's research infrastructure is a thing of beauty.
Is its continued evolution necessary? Always! That's good policy and good science.
But, our primary focus should be expanding and strengthening the NIH, not stalling it. (4/4) 🧪
Reposted by BioloBri 🧬👩🏻🔬✨
Sure, the NIH can be improved. I, too, have critiques on grant review.
But, its existing processes already offer substantial societal benefits while helping the US lead the #biotech sector.
That's good for science, our citizens, and US national security. (3/4) 🧪
www.csis.org/blogs/strate...
But, its existing processes already offer substantial societal benefits while helping the US lead the #biotech sector.
That's good for science, our citizens, and US national security. (3/4) 🧪
www.csis.org/blogs/strate...
The Strategic Imperative of Biotechnology: Implications for U.S. National Security | Strategic Technologies Blog | CSIS
This blog post explores the critical role of biotech innovation for U.S. national security in the context of strategic competition with China.
www.csis.org
January 23, 2025 at 5:56 PM
Sure, the NIH can be improved. I, too, have critiques on grant review.
But, its existing processes already offer substantial societal benefits while helping the US lead the #biotech sector.
That's good for science, our citizens, and US national security. (3/4) 🧪
www.csis.org/blogs/strate...
But, its existing processes already offer substantial societal benefits while helping the US lead the #biotech sector.
That's good for science, our citizens, and US national security. (3/4) 🧪
www.csis.org/blogs/strate...
Reposted by BioloBri 🧬👩🏻🔬✨
You'd be hard-pressed to find a better return for our taxes.
For every dollar of research funding, the NIH generates $2.46 in economic activity. 👀
Let's not understate that. Delaying NIH study sections, stalls a ~2.5X ROI & leaves value on the table. (2/4) 🧪
www.fiercebiotech.com/research/rep...
For every dollar of research funding, the NIH generates $2.46 in economic activity. 👀
Let's not understate that. Delaying NIH study sections, stalls a ~2.5X ROI & leaves value on the table. (2/4) 🧪
www.fiercebiotech.com/research/rep...
Report: Every dollar of NIH research funding doubles in economic returns
Research funded by the National Institutes of Health (NIH) generated $2.46 in economic activity for every $1 of funding in 2023, a total of $92.9 billion, according to an
www.fiercebiotech.com
January 23, 2025 at 5:56 PM
You'd be hard-pressed to find a better return for our taxes.
For every dollar of research funding, the NIH generates $2.46 in economic activity. 👀
Let's not understate that. Delaying NIH study sections, stalls a ~2.5X ROI & leaves value on the table. (2/4) 🧪
www.fiercebiotech.com/research/rep...
For every dollar of research funding, the NIH generates $2.46 in economic activity. 👀
Let's not understate that. Delaying NIH study sections, stalls a ~2.5X ROI & leaves value on the table. (2/4) 🧪
www.fiercebiotech.com/research/rep...